08.12.2012 Views

Interventions for Tuberculosis Control and Elimination 2002

Interventions for Tuberculosis Control and Elimination 2002

Interventions for Tuberculosis Control and Elimination 2002

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

thus suggested equivalence (the hypothesis of the study) between the two<br />

regimens. Completion of therapy was superior in the experimental compared<br />

to the control arm.<br />

In the United States, preventive chemotherapy regimens using rifampicin<br />

(plus pyrazinamide) of two to four months’ duration have been recommended.<br />

897 However, recent reports on fatal <strong>and</strong> severe hepatitis associated<br />

with preventive therapy using rifampicin plus pyrazinamide 904 have<br />

led to a change of the recommendation <strong>and</strong> advising great caution in the<br />

use of this combination. 904<br />

Effectiveness of preventive chemotherapy<br />

There can be little doubt about the efficacy of preventive chemotherapy, at<br />

least with isoniazid if given <strong>for</strong> twelve months to persons with tuberculous<br />

infection without additional risk factors. There are indications that a regimen<br />

of nine months’ duration might still be similarly efficacious in reducing<br />

the risk of tuberculosis. The efficacy of isoniazid in patients with risk<br />

factors is much less well established, <strong>and</strong> many studies dealing with HIVinfected<br />

patients suffer from inadequate sample sizes. It also seems that<br />

rifampicin-containing regimens of shorter duration can af<strong>for</strong>d similar protection,<br />

but the optimal duration <strong>and</strong> the role of companion drugs have not<br />

been sufficiently well established. A short-coming of most preventive<br />

chemotherapy trials has been the self-administration of medications, thus<br />

portraying more the effectiveness than the potential efficacy of the regimen<br />

in question.<br />

All studies that have evaluated that component have clearly demonstrated<br />

the adverse effect of non-adherence on the regimen’s efficacy, as<br />

would be expected. This has been the case even in the setting of clinical<br />

trials where adherence might be better than under daily operations within<br />

the context of a national program.<br />

Several studies have also demonstrated that the type of patients who<br />

are selected <strong>for</strong> preventive chemotherapy is important, <strong>and</strong> that large numbers<br />

may have to be treated to prevent a single case if the persons selected<br />

have a low risk of tuberculosis.<br />

In a simplified <strong>for</strong>m, operational effectiveness can thus be summarized<br />

as the product of tuberculosis risk given the presence of tuberculous infection,<br />

the efficacy of the regimen, <strong>and</strong> adherence to the prescribed medications.<br />

In a few examples, table 11 summarizes different situations <strong>and</strong> the<br />

143

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!